EA200600531A1 - Сочетание ингибитора обратного захвата серотонина и локсапина - Google Patents

Сочетание ингибитора обратного захвата серотонина и локсапина

Info

Publication number
EA200600531A1
EA200600531A1 EA200600531A EA200600531A EA200600531A1 EA 200600531 A1 EA200600531 A1 EA 200600531A1 EA 200600531 A EA200600531 A EA 200600531A EA 200600531 A EA200600531 A EA 200600531A EA 200600531 A1 EA200600531 A1 EA 200600531A1
Authority
EA
Eurasian Patent Office
Prior art keywords
loxapine
combination
serotonin
reverse capture
inhibitor
Prior art date
Application number
EA200600531A
Other languages
English (en)
Inventor
Томас Иво Франсискус Хуберт Кремерс
Сандра Хогг Виллиджерс
Иерн Арнт
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2004/000581 external-priority patent/WO2005023243A1/en
Publication of EA200600531A1 publication Critical patent/EA200600531A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к применению сочетания локсапина и ингибитора обратного захвата серотонина (ИОЗС) для лечения депрессии и других аффективных нарушений.
EA200600531A 2003-09-04 2004-09-01 Сочетание ингибитора обратного захвата серотонина и локсапина EA200600531A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301270 2003-09-04
PCT/DK2004/000581 WO2005023243A1 (en) 2003-09-04 2004-09-01 The combination of a serotonin reuptake inhibitor and loxapine

Publications (1)

Publication Number Publication Date
EA200600531A1 true EA200600531A1 (ru) 2006-08-25

Family

ID=58707235

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600531A EA200600531A1 (ru) 2003-09-04 2004-09-01 Сочетание ингибитора обратного захвата серотонина и локсапина

Country Status (7)

Country Link
US (1) US20070042014A1 (ru)
KR (1) KR20060072127A (ru)
CN (1) CN1845730A (ru)
EA (1) EA200600531A1 (ru)
IL (1) IL173968A0 (ru)
IS (1) IS8326A (ru)
ZA (1) ZA200601459B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009020897A1 (en) * 2007-08-03 2009-02-12 Forest Laboratories Holdings Limited Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine recptor ligands
WO2012054815A1 (en) 2010-10-22 2012-04-26 Duke University Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies
CN107556206A (zh) * 2016-06-30 2018-01-09 陕西合成药业股份有限公司 一种新型5‑羟色胺再摄取抑制剂类化合物及其制备方法和在医学上的应用
EP3854391B1 (en) * 2018-09-21 2024-03-13 SK Biopharmaceuticals Co., Ltd. Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder

Also Published As

Publication number Publication date
IL173968A0 (en) 2006-07-05
CN1845730A (zh) 2006-10-11
US20070042014A1 (en) 2007-02-22
ZA200601459B (en) 2007-05-30
IS8326A (is) 2006-02-23
KR20060072127A (ko) 2006-06-27

Similar Documents

Publication Publication Date Title
UY28041A1 (es) Metodos de dosis bajas para el tratamiento de trastornos en los cuales la actividad del tnfa es perjudicial.
NO20060242L (no) Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatin
CY1112238T1 (el) Αναστολεις μιτωτικης κινεσινης και μεθοδοι χρησης αυτων
TW200602048A (en) Diphenylimidazopyrimidine and -imidazole amines as inhibitors of β -secretase
MX2008002293A (es) Uso novedoso de compuestos peptidicos para tratar dolor muscular.
PA8596901A1 (es) Inhibidores de p38 y metodos de uso de ellos
EA200601841A1 (ru) Композиции, содержащие ингибитор jnk и циклоспорин
RS20050392A (en) Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor
BRPI0515518A (pt) análogos de loxapina e métodos de usos dos mesmos
EA200700909A1 (ru) Азаиндолкарбоксамиды
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
DK1701940T3 (da) 2-(1H-indolylsulfanyl)-bensylaminderivater som SSRI
EE200400005A (et) Tablett, mis sisaldab vähemalt kahte eristatavat segmenti ning selle kasutamine
HRP20050579B1 (hr) Nove sinergistiäśne kombinacije koje sadrže roflumilast i formoterol
NO20061425L (no) Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin
NO20042904L (no) Anvendelse av norepinefrin-reopptakinhibitorer for behandling av kognitiv svikt
EA200600531A1 (ru) Сочетание ингибитора обратного захвата серотонина и локсапина
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη
EA200501802A1 (ru) Сочетание аналептина модафинила и антидепрессанта для лечения депресии
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
ATE392212T1 (de) Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen
EA200600183A1 (ru) Сочетание ингибитора обратного захвата серотонина и агомелатина
DE602004011679D1 (de) Behandelung von Störungen
TNSN05154A1 (en) Use of levocetirizine for the treatment of persistent allergic rhinitis